Singleron Biotechnologies
Jing Zhou serves as the President of Singleron Biotechnologies since March 2018, focusing on the research and development of high throughput single-cell analysis technologies and expanding the US market. Previously, Jing Zhou held the position of Vice President of Engineering at Singleron, overseeing microfluidics based single-cell analysis platforms for clinical applications. As a Review Editor for Frontiers in Bioengineering and Biotechnology, Jing Zhou certifies the validity of publications. Past experiences also include roles as a Patent Agent and Technology Specialist at Dilworth IP, Advisor to the CEO at IsoPlexis, Associate Research Scientist/Lecturer at Yale University, and Guest Research Associate at NIST. Jing Zhou completed a PhD and MS in Mechanical Engineering at the University of California, Berkeley, following a BS in Modern Mechanics from the University of Science and Technology of China.
This person is not in any offices
Singleron Biotechnologies
1 followers
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com